Cofund Fellowship Program

Next Cofund deadlines: 28th July 2015 and 15th October 2015

If you are an experienced researcher, this is your opportunity to advance and disseminate your research in neglected diseases such as tuberculosis, malaria, Chagas disease, and leishmaniasis. The Tres Cantos Open Lab Foundation (TCOLF) Cofund Fellowship will give you access to GSK drug discovery expertise and industrial-scale facilities in Tres Cantos, Spain.


The Fellowship is partially funded by the European Commission through its FP7 Marie Curie co-funding program.

Why You Should Apply

There is simply no better place than Tres Cantos to explore innovative approaches to address neglected diseases. You'll be working side-by-side with Open Lab researchers and GSK scientists in a collaborative atmosphere. You'll explore innovative approaches to research, apply new skills and improve your career opportunities - all while contributing to the treatment of diseases that affect millions of people.

Qualifications to Apply

  • Institutional endorsement to carry out the project
  • Project aligned with the strategic objectives of the Foundation with a maximum duration of 24 months.
  • Experience: Researchers must, at the time of deadline for submission of proposals, be in possession of a doctoral degree or have at least four years of full-time equivalent research experience. Full-time equivalent research experience is measured from the date when a researcher obtained the degree that would formally entitle him or her to embark on a doctorate, either in the country in which the degree was obtained or in the country in which the research training is provided.
  • Mobility: Researchers must not have resided or carried out their main activity (work, studies, etc.) in the country where more than half of the project is implemented for more than 12 months in the 3 years immediately prior to the reference date (deadline for submission of proposals). Compulsory national service and/or short stays, such as holidays, are not taken into account.
  • Residence: the applicant must be resident in a Member State or Country Associated to FP7 by the application deadline ONLY in the case that more than half of the project is implemented at the home institution premises AND the home institution is not located in an EU Member State or Country Associated to FP7.
  • Completeness of the application: Only complete applications will be evaluated.

Please refer to the Guide for Applicants & FAQs for additional information on the eligibility criteria and application process.

Concept of "Home" and "Host" Institution

"Home Institutions" can be public or private Research Institutes, High Education Institutions or Companies working in the research areas supported by TCOLF. The "Host institution" is GSK's Tres Cantos Medicines Development Campus (GSK TCMDC) near Madrid, Spain. TCOLF supports collaborative projects between a "Home" and the "Host" institution. They can be implemented entirely at the GSK TCMDC, or at both the Home and the Host Institution facilities; timelines at each site must be coherent with the expertise and resources available at each site.

If you plan to submit a Cofund application, you need to obtain support by a Home Institution of your choice to implement the proposed project. Below is a list of potential Home Institutions. It does not represent any restriction to apply with support of any other Home Institution.

Home Institutions for applications with deadline 28th July 2015 (this list may be enlarged any time during the call):

  • Malaria - The Francis Crick Institute, Principal Investigator: Dr. Holder, Tony.Holder[at]crick.ac.uk
  • Malaria - St. George's, University of London, Principal Investigator: Prof. Krishna , sgjf100[at]sgul.ac.uk
  • Malaria - London School of Higiene and Tropical Medicine, Principal Investigator: Prof. Croft Simon.Croft[at]lshtm.ac.uk
  • Malaria - Imperial College, Principal Investigator: Dr. Baum, jake.baum[at]imperial.ac.uk
  • Malaria - Sanger Institute, Principal Investigators: Dr. Billker , ob4[at]sanger.ac.uk, Dr. Lee, ml31[at]sanger.ac.uk, Dr. Rayner, jr9[at]sanger.ac.uk
  • Tuberculosis - University of Birmingham, Principal Investigator: Prof. Besra, g.besra[at]bham.ac.uk
  • Tuberculosis - University of British Columbia, Principal Investigator: Prof. Av-Gay, yossi[at]mail.ubc.ca
  • Tuberculosis - EPFL / École polytechnique fédérale de Lausanne, Principal Investigator: Prof. McKinney, john.mckinney[at]epfl.ch
  • Kinetoplastids - University of Dundee, Principal Investigators: Dr. Read, K.Read[at]dundee.ac.uk, Prof. Wyatt, p.g.wyatt[at]dundee.ac.uk, Dr. Gray; d.w.gray[at]dundee.ac.uk, Prof. Gilbert, I.H.Gilbert[at]dundee.ac.uk, Prof. Ferguson, m.a.j.ferguson[at]dundee.ac.uk, Prof. Horn, d.horn[at]dundee.ac.uk.
  • Kinetoplastids - University of Georgia, Principal Investigators: Prof. Tarleton, tarleton[at]uga.edu
  • Kinetoplastids - London School of Higiene and Tropical Medicine, Principal Investigators: Prof. Croft, Simon.Croft[at]lshtm.ac.uk and Prof. Kelly, john.kelly[at]lshtm.ac.uk
  • Kinetoplastids - University of Glasgow, Principal Investigators: Michael Barrett, Michael.Barrett[at]glasgow.ac.uk, Jeremy Mottram, Jeremy.Mottram[at]glasgow.ac.uk
  • Kinetoplastids - Laval University Québec, Principal Investigator: Dr. Ouellette, marc.ouellette[at]crchudequebec.ulaval.ca

Home Institutions for applications with deadline 15th October 2015 (this list may be enlarged any time during the call):

  • Malaria - St. George's, University of London, Principal Investigator: Prof. Krishna , sgjf100[at]sgul.ac.uk
  • Malaria - London School of Higiene and Tropical Medicine, Principal Investigators: Prof. Croft Simon.Croft[at]lshtm.ac.uk
  • Malaria- Imperial College, Principal Investigator: Dr. Baum, jake.baum[at]imperial.ac.uk
  • Tuberculosis - St George's University of London, Principal investigator: Dr Yanmin Hu, ymhu[at]sgul.ac.uk
  • Tuberculosis - University of Birmingham, Principal Investigator: Prof. Besra, g.besra[at]bham.ac.uk
  • Tuberculosis - University of British Columbia, Principal Investigator: Prof. Av-Gay, yossi[at]mail.ubc.ca
  • Tuberculosis - EPFL / École polytechnique fédérale de Lausanne, Principal Investigator: Prof. McKinney, john.mckinney[at]epfl.ch
  • Kinetoplastids - University of Dundee, Principal Investigators: Dr. Read, K.Read[at]dundee.ac.uk, Prof. Wyatt, p.g.wyatt[at]dundee.ac.uk, Dr. Gray; d.w.gray[at]dundee.ac.uk, Prof. Gilbert, I.H.Gilbert[at]dundee.ac.uk, Prof. Ferguson, m.a.j.ferguson[at]dundee.ac.uk, Prof. Horn, d.horn[at]dundee.ac.uk.
  • Kinetoplastids - University of Georgia, Principal Investigators: Prof. Tarleton, tarleton[at]uga.edu
  • Kinetoplastids - London School of Higiene and Tropical Medicine, Principal Investigators: Prof. Croft, Simon.Croft[at]lshtm.ac.uk and Prof. Kelly, john.kelly[at]lshtm.ac.uk
  • Kinetoplastids - University of Glasgow, Principal Investigators: Michael Barrett, Michael.Barrett[at]glasgow.ac.uk, Jeremy Mottram, Jeremy.Mottram[at]glasgow.ac.uk
  • Kinetoplastids - Laval University Québec, Principal Investigator: Dr. Ouellette, marc.ouellette[at]crchudequebec.ulaval.ca


1. Download

COFUND_Application.docx


2. Submit your
completed proposal